Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Benzazepines
  7. 0922100

SKF 38393 hydrobromide, Tocris Bioscience™

Catalog No. 0922100
Click to view available options
Quantity:
100 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Selective D1-like agonist

Prototypical D1-like dopamine receptor selective partial agonist (Ki values are 1, ∽ 0.5, ∽ 150, ∽ 5000 and ∽ 1000 nM for D1, D5, D2, D3 and D4 receptors respectively).

Chemical Identifiers

CAS 20012-10-6
Molecular Formula C16H18BrNO2
Molecular Weight (g/mol) 336.229
InChI Key INNWVRBZMBCEJI-UHFFFAOYSA-N
Synonym skf 38393 hydrobromide, 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol hydrobromide, 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diolhydrobromide, +/--1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol hydrobromide, 1h-3-benzazepine-7,8-diol,2,3,4,5-tetrahydro-1-phenyl, 1-phenyl-2,3,4,5-tetrahydro-1h-benzo d azepine-7,8-diol hydrobromide, 7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrobromide
PubChem CID 12928470
IUPAC Name 5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;hydrobromide
SMILES C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3.Br

Specifications

Quantity 100 mg
Percent Purity >99%
Physical Form Solid
Chemical Name or Material SKF 38393 hydrobromide

Safety and Handling

Recommended Storage Desiccate at -20°C
Provide Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.